Physician profile
Michael Morio
NPI 1386087658
$2,148.66
in general payments reported to CMS, 2019-2025
7 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $230 · 2021: $455 · 2022: $398 · 2023: $225 · 2024: $454 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.47 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,196.63 | 2019-2025 | |
| Nobel Biocare USA | $349.71 | 2021-2023 | Nobelactive |
| Dentsply Sirona INC | $244.78 | 2021-2023 | Astra Tech Implant System |
| Salvin Dental Specialties, INC. | $220.29 | 2021 | |
| Geistlich Pharma, North America, INC. | $74.58 | 2019-2020 | |
| Zimvie INC. | $32.18 | 2024 | |
| Ace Surgical Supply Co., INC. | $30.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Morio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.